At the request of Congress, in 2008 NIH began releasing to the public how much the agency spends in various research categories. I decided to pick out the top-funded disease areas to get a sense of what disorders and diseases the U.S. government is prioritizing. The red and green arrows indicate whether categories had a decrease or bump in funding from the previous year, respectively.
In an era of massive clinical trial failures and R&D cutbacks in Big Pharma, drug developers are searching for ways to test drug candidates more accurately and cost-efficiently before pouring millions of dollars into clinical trials. New technology like organs-on-chips and bioprinted tissues have the potential to test the safety of drugs more effectively for a myriad of diseases.
Organizations from both the private sector and academia are working on such technology to help drug developers advance new therapies toward FDA approval.
FierceBiotech is now available on iPhone and iPad!
This is the best FierceBiotech reading experience we've ever created. Swipe right-to-left within articles to quickly scan the latest news. Get breaking news alerts sent to your mobile device so you're the first to know when a major story unfolds. Download it today; the app is an essential complement to our e-mail newsletter and website.
Android users: We're on track to have an app complete by the end of the year.
Have something to say? Join the conversation at
FierceBiotech's LinkedIn group.
POPULAR COMMENT THREADS
Injecting a gene directly into the heart may be able to replace the need for an electronic pacemaker, according to new research by scientists at the Cedars-Sinai Heart Institute.
In response to back-to-back incidents involving government laboratories, a top official at the U.S. Centers for Disease Control and Prevention has resigned, and the agency has assembled a safety board to address concerns that have arisen after workers were potentially exposed to anthrax and H5N1 flu.
Researchers at the University of Iowa have developed a vaccine that showed protection in mice against dust mite allergies.
Startup Neurotrope is teaming up with the Icahn School of Medicine at Mount Sinai in New York City to further develop its bryostatins for the treatment of Niemann-Pick disease type C, a rare disease that mostly affects children.
In 2008, the U.S. National Institutes of Health began releasing to the public how much the agency spends in various research categories. I decided to pick out the top-funded disease areas to get a sense of what disorders and diseases the U.S. government is prioritizing.
A new discovery of an ancestral fossil virus buried within everyone's genomes might provide the key to eradicating HIV.
From Our Sister Sites
Scientific evidence proves a correlation between nonmedical use of antibiotics to fatten farm animals and spikes in antibiotic-resistant infections. So why was a federal appeals court panel divided over whether these drugs can be added to animal feed even if the drugs aren't medically necessary? The short, simple answer is that the FDA has just been giving advice on the practice.
Merck is going through a complete makeover, buying and selling units at a rapid pace. And some of its employees are getting caught in its "out with the old and in with the new" philosophy. Now 600 sales reps have been told their services are no longer needed